115 related articles for article (PubMed ID: 25960995)
1. Expression of Multidrug Resistance Transporter ABCB5 in a Murine Model of Human Conjunctival Melanoma.
de Waard NE; Kolovou PE; McGuire SP; Cao J; Frank NY; Frank MH; Jager MJ; Ksander BR
Ocul Oncol Pathol; 2015 Apr; 1(3):182-189. PubMed ID: 25960995
[TBL] [Abstract][Full Text] [Related]
2. A Murine Model for Metastatic Conjunctival Melanoma.
de Waard NE; Cao J; McGuire SP; Kolovou PE; Jordanova ES; Ksander BR; Jager MJ
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2325-33. PubMed ID: 25722211
[TBL] [Abstract][Full Text] [Related]
3. Genetically determined ABCB5 functionality correlates with pigmentation phenotype and melanoma risk.
Lin JY; Zhang M; Schatton T; Wilson BJ; Alloo A; Ma J; Qureshi AA; Frank NY; Han J; Frank MH
Biochem Biophys Res Commun; 2013 Jul; 436(3):536-42. PubMed ID: 23770371
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines.
Xiao J; Egger ME; McMasters KM; Hao H
BMC Cancer; 2018 Jun; 18(1):675. PubMed ID: 29929490
[TBL] [Abstract][Full Text] [Related]
5. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma.
Frank NY; Margaryan A; Huang Y; Schatton T; Waaga-Gasser AM; Gasser M; Sayegh MH; Sadee W; Frank MH
Cancer Res; 2005 May; 65(10):4320-33. PubMed ID: 15899824
[TBL] [Abstract][Full Text] [Related]
6. Stem-Mesenchymal Signature Cell Genes Detected in Heterogeneous Circulating Melanoma Cells Correlate With Disease Stage in Melanoma Patients.
Rapanotti MC; Campione E; Suarez Viguria TM; Spallone G; Costanza G; Rossi P; Orlandi A; Valenti P; Bernardini S; Bianchi L
Front Mol Biosci; 2020; 7():92. PubMed ID: 32548126
[TBL] [Abstract][Full Text] [Related]
7. Outbreak of Opportunistic Ascending Pyelonephritis with Numerous Yeast after Experimental Humanization Surgery in NOD.Cg-
Zadrozny LM; Brinster LR; Rosenzweig BA; Howard KE
Comp Med; 2018 Oct; 68(5):353-359. PubMed ID: 30208988
[TBL] [Abstract][Full Text] [Related]
8. Expression of SOX10, ABCB5 and CD271 in melanocytic lesions and correlation with survival data of patients with melanoma.
Gambichler T; Petig AL; Stockfleth E; Stücker M
Clin Exp Dermatol; 2016 Oct; 41(7):709-16. PubMed ID: 27663144
[TBL] [Abstract][Full Text] [Related]
9. ABCB5 promotes melanoma metastasis through enhancing NF-κB p65 protein stability.
Wang S; Tang L; Lin J; Shen Z; Yao Y; Wang W; Tao S; Gu C; Ma J; Xie Y; Liu Y
Biochem Biophys Res Commun; 2017 Oct; 492(1):18-26. PubMed ID: 28821433
[TBL] [Abstract][Full Text] [Related]
10. ΔNp73 regulates the expression of the multidrug-resistance genes ABCB1 and ABCB5 in breast cancer and melanoma cells - a short report.
Sakil HAM; Stantic M; Wolfsberger J; Brage SE; Hansson J; Wilhelm MT
Cell Oncol (Dordr); 2017 Dec; 40(6):631-638. PubMed ID: 28677036
[TBL] [Abstract][Full Text] [Related]
11. ABCB5-Targeted Chemoresistance Reversal Inhibits Merkel Cell Carcinoma Growth.
Kleffel S; Lee N; Lezcano C; Wilson BJ; Sobolewski K; Saab KR; Mueller H; Zhan Q; Posch C; Elco CP; DoRosario A; Garcia SS; Thakuria M; Wang YE; Wang LC; Murphy GF; Frank MH; Schatton T
J Invest Dermatol; 2016 Apr; 136(4):838-846. PubMed ID: 26827764
[TBL] [Abstract][Full Text] [Related]
12. In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials.
Tappenbeck N; Schröder HM; Niebergall-Roth E; Hassinger F; Dehio U; Dieter K; Kraft K; Kerstan A; Esterlechner J; Frank NY; Scharffetter-Kochanek K; Murphy GF; Orgill DP; Beck J; Frank MH; Ganss C; Kluth MA
Cytotherapy; 2019 May; 21(5):546-560. PubMed ID: 30878384
[TBL] [Abstract][Full Text] [Related]
13. ABCB5 expression and cancer stem cell hypothesis in oral squamous cell carcinoma.
Grimm M; Krimmel M; Polligkeit J; Alexander D; Munz A; Kluba S; Keutel C; Hoffmann J; Reinert S; Hoefert S
Eur J Cancer; 2012 Nov; 48(17):3186-97. PubMed ID: 22784549
[TBL] [Abstract][Full Text] [Related]
14. The influence of nano-TiO2 on metabolic activity, cytotoxicity and ABCB5 mRNA expression in WM-266-4 human metastatic melanoma cell line.
Zdravkovic B; Zdravkovic TP; Zdravkovic M; Strukelj B; Ferk P
J BUON; 2019; 24(1):338-346. PubMed ID: 30941990
[TBL] [Abstract][Full Text] [Related]
15. A Novel Model of Metastatic Conjunctival Melanoma in Immune-Competent Mice.
Schlereth SL; Iden S; Mescher M; Ksander BR; Bosch JJ; Cursiefen C; Heindl LM
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5965-73. PubMed ID: 26377082
[TBL] [Abstract][Full Text] [Related]
16. Expression of the Stem Cell Marker ABCB5 in Normal and Tumor Tissues.
Saeed MEM; Boulos JC; Machel K; Andabili N; Marouni T; Roth W; Efferth T
In Vivo; 2022; 36(4):1651-1666. PubMed ID: 35738589
[TBL] [Abstract][Full Text] [Related]
17. Expression of Cell-Surface Marker ABCB5 Causes Characteristic Modifications of Glucose, Amino Acid and Phospholipid Metabolism in the G3361 Melanoma-Initiating Cell Line.
Lutz NW; Banerjee P; Wilson BJ; Ma J; Cozzone PJ; Frank MH
PLoS One; 2016; 11(8):e0161803. PubMed ID: 27560924
[TBL] [Abstract][Full Text] [Related]
18. CD8-positive lymphocytes in graft-versus-host disease of humanized NOD.Cg-Prkdc(scid)Il2rg(tm1Wjl)/SzJ mice.
Laing ST; Griffey SM; Moreno ME; Stoddart CA
J Comp Pathol; 2015; 152(2-3):238-42. PubMed ID: 25670669
[TBL] [Abstract][Full Text] [Related]
19. Detection of ABCB5 tumour antigen-specific CD8
Borchers S; Maβlo C; Müller CA; Tahedl A; Volkind J; Nowak Y; Umansky V; Esterlechner J; Frank MH; Ganss C; Kluth MA; Utikal J
Clin Exp Immunol; 2018 Jan; 191(1):74-83. PubMed ID: 28940439
[TBL] [Abstract][Full Text] [Related]
20. Expression and clinical significance of TYRP1, ABCB5, and MMP17 in sinonasal mucosal melanoma.
Tu J; Wang J; Tang B; Zhang Z; Han M; Li M; Yu J; Shen L; Zhang M; Ye J
Cancer Biomark; 2022; 35(3):331-342. PubMed ID: 36373310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]